Market Overview

Benzinga's Top Initiations

Related CLDX
5 Companies Developing New Cancer Drugs
5-Star Biotech Stock Watch: Celldex Therapeutics
Related BFAM
UPDATE: Bank Of America Reiterates On Bright Horizons Family Solutions On Strong Start To 2014
What Falling Estimates & Price Mean for Bridgepoint Education (BPI) - Tale of the Tape
Working Parents' Continued Struggle: Torn Between Kids and Job (Fox Business)

Analysts at Leerink initiated coverage on shares of Celldex Therapeutics (NASDAQ: CLDX) with an “outperform” rating. The target price range for Celldex is set to $18. Celldex's shares closed at $10.71 yesterday.

Credit Suisse initiated coverage on shares of Bright Horizons Family Solutions LLC (NYSE: BFAM) with an “outperform” rating. The target price for Bright Horizons is set to $35. Bright Horizons' stock closed at $28.35 yesterday.

RBC Capital initiated coverage on shares of Walter Energy (NYSE: WLT) with a “sector perform” rating. The target price for Walter Energy is set to $34. Walter Energy's shares closed at $29.76 yesterday.

Analysts at Roth Capital initiated coverage on shares of Cytori Therapeutics (NASDAQ: CYTX) with a “buy” rating. The target price for Cytori Therapeutics is set to $8. Cytori Therapeutics' shares closed at $2.69 yesterday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (CLDX + BFAM)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional